Revance Therapeutics (NASDAQ:RVNC) is set to give its latest quarterly earnings report on Wednesday, 2024-02-28. Here’s what investors need to know before the announcement.
Analysts estimate that Revance Therapeutics will report an earnings per share (EPS) of $-0.72.
Revance Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …